Osteoporosis is characterized by low bone mass with skeletal fragility and an increased risk of fracture. This bone loss is caused by an imbalance between bone resorption and formation. Cathepsin K (CTSK, CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD) is the most abundant expressed cysteine protease in the osteoclasts and is thought to contribute to the degradation of bone matrix necessary for bone resorption. Cathepsin K plays an important role in osteoporosis and other bone-related pathologies, cancer, diabetes, obesity and atherosclerosis. Pharmacologically, effective anti-osteoporosis drugs are able to significantly stimulate bone formation or at least inhibit bone resorption but not bone formation. It seems that cathepsin K inhibitors are better choice which can limit osteoclast activity without reducing osteoblast function. In this way, cathepsin K inhibitors represent a new target for the development of drugs for the treatment of osteoporosis and other diseases characterized by increased bone resorption.
BOC Sciences has developed a cathepsin K targeted library to offer 761 compounds with predicted inhibiting activity against this protease and suitable for the early stage of drug discovery.
Figure 1. Cathepsin K inhibition for the treatment of osteoporosis. (Le, T.; et al. 2016)
Overall, BOC Sciences has used a receptor-based virtual screen to design this unique library:
BOC Sciences’ Cathepsin K targeted library includes a diversity of therapeutically relevant compounds that are carefully selected from our proprietary collection of HTS compounds to meet the parameters listed in the table below.
Table1. The summary of the BOC Sciences Cathepsin K Targeted Library characteristics
Parameter | Value |
MW | 260-500 |
Number of H Donors | 0-4 |
Number of H Acceptors | 0-9 |
Number of Rotatable Bonds | 0-8 |
Number of Rings | 3-6 |
Number of Aromatic Rings | 0-5 |
Number of Halogen Atoms | 0-5 |
Polar Surface Area | 10-90 |
Calculated LogS | -9--2.2 |
Calculated LogP | -0.5-5 |
Fraction of Sp3-Hybridized Carbons | 0-0.7 |
PSA | 32-184 |
Drug-like | 100% |
Lead-like | 31% |
BOC Sciences provides professional, rapid and high-quality services of Cathepsin K Targeted Library design at competitive prices for global customers. Personalized and customized services of Cathepsin K Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.